Annotation-Free Prediction of Cancer Cells and Glands and Spatial Analysis of Immune Cells.

Prostate cancer is classified as "immune-cold" due to limited infiltration of immune cells and no clear correlation between immune cells and clinical outcomes. However, immune cells are found in prostate cancers and the spatial relationships between these immune cells and cancer cells/glands have not been investigated, partly due to a lack of automated tools that classify both cancerous cells/glands. In this paper, we have developed an end-to-end tool (TOPAZ: issue rganization identification using stial proteomics) that combines multiplexed single-cell protein data with histology images to: 1) predict cancerous versus non-cancerous epithelial cells using a Gaussian-mixture model; 2) predict cancerous/non-cancerous gland type using a principal curve estimation. Using TOPAZ to assign cancer and non-cancerous labels to cells and glands, we extracted multiscale spatial features from the classification results-including immune dense-region geometrical features and cell-to-gland distances-and correlated the features with risk of biochemical recurrence and cancer grade. Tissue-microarrays containing 753 cores from 217 prostate cancer patients underwent multiplexed immunofluorescent imaging (Cell DIVE, Leica) for epithelial cell markers (panCK26, S6, NaKATPase), basal cell markers (p63, CK5), a cancer cell marker (AMACR), and T cell markers (CD3, CD4, CD8, FOXP3, CD68). Cancerous/non-cancerous cell classification from TOPAZ achieved 82% sensitivity and 99% specificity against expert annotation, and the pipeline further predicted cancerous/non-cancerous glands without manual threshold tuning. Regulatory-T-cell and helper-T-cell percentages decreased, and macrophage percentage increased with grade increase (P < 0.05). When the median distance from cancerous gland centroids to the nearest regulatory or helper T-cell exceeded approximately 50 μm, the hazard of biochemical recurrence doubled (log-rank P < 0.01). The open-source Shiny app TOPAZ (https://chunglab.bmi.osumc.edu/TOPAZ) packages the workflow, predicting individual cell types and gland shapes. By combining probabilistic cell typing with gland-shape modeling, TOPAZ yields interpretable multiscale spatial features linked to prognosis and is released as an open web app for unrestricted use.